Escherichia genomics, India s biotech company prioritizes delivering affordable innovation in basic molecular biology, Clinical molecular biology and diagnostics molecular biology. It is devoted to reduce research costs of basic molecular biology, Clinical molecular biology and diagnostics molecular biology by leveraging india s cost advantage to deliver affordable technology and services solutions to industry, Institutions, Partners and healthcare systems Throughout the worldescherichia genomics s key innovations include first laureates dna kits, Laureates rna kits delivering first indigenously produced technology that enable dna isolation so quick less than 5 minutes from plant system, Microbial system and blood system. Usr32 is a next generation affordable gel doc system.

Our Story

Company Introduction

Watch Video
No introduction video available
Company Overview

Learn about our journey from a startup to a global leader in smart security solutions

Company Timeline

2010

Founded

Started as a small team of security technology enthusiasts in Shenzhen

2026

Global Expansion

Expanded operations internationally and established a strong presence in key global markets, marking a significant milestone in our company's growth and commitment to delivering quality solutions worldwide.

Overview

Monthly Supply Capacity

-

Annual Turnover

₹1 Crore – ₹2 Crore

Main Markets

-

Nearest Export Port

-

Accepted Delivery Terms

-

Key Facts

Team Size
N/A

Skilled professionals across R&D, manufacturing, and support

Annual Turnover
₹1 Crore – ₹2 Crore

Consistent growth with strong financial performance

Main Markets
N/A

Worldwide presence with dedicated regional support

Manufacturing Excellence

-
Factory Area
2
Production Lines

State-of-the-art manufacturing facility with automated production lines and strict quality control processes.